Ignite Creation Date:
2024-07-17 @ 11:04 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06493279
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-07-02
Brief Title:
Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis
Sponsor:
Rejukon Biopharm Inc
Organization:
Rejukon Biopharm Inc
Organization Data
Organization:
Rejukon Biopharm Inc
Class:
INDUSTRY
Study ID:
RJK002-0001-R
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rejukon Biopharm Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None